NeuroOne Medical Technologies Corporation (NMTC) Stock

NeuroOne Medical Technologies Corporation (NMTC) is a Healthcare stock trading at $3.29 (as of 2026-06-18), with a market capitalization of $33.97M and a trailing P/E of -7.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

NeuroOne Medical Technologies Corporation develops and commercializes medical technology including thin film electrode systems for continuous EEG and stereo-EEG recording, as well as applications involving spinal cord stimulation, brain stimulation, and ablation. Its products are intended for patients with neurological conditions such as epilepsy and movement or pain disorders.

Valuation — source: SEC EDGAR (first-party)
Price	$3.29
Market Cap	$33.97M
P/E Ratio	-7.0
EV / EBITDA	-4.1
Price / Book	5.69
Price / Sales	3.15
DCF Value (model)	$-0.86
DCF Upside vs Price	-126.1%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$9.10M
Net Margin	-39.6%
Return on Equity	-123.6%
Current Ratio	4.38
Revenue Growth (YoY)	163.5%
EPS Growth (YoY)	-80.4%
FCF Growth (YoY)	-73.8%

Financial Health — source: SEC EDGAR
Altman Z-Score	17.04 (safe)

Valuation vs Sector & Industry
Stock P/E	-7.0
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-133.2%
vs Industry	-121.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	Bleichroeder LP ($3.11M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	David A. Rosa
Employees	17
Country	US
IPO Date	2018-03-15

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.